All Announcements
Industrial policies outlined in the 13th Five-Year Plan (2016-2020) and related policy announcements seek to move Chinese manufacturing up the value-added chain, establish China as a global center of innovation and technology, and ensure China’s long-term productivity in critical dual-use technologies such as computing, robotics, and biotechnology. Advancements in these sectors have previously…
The U.S.-China Economic and Security Review Commission invites submission of proposals to provide a one-time unclassified report on Chinese entities’ use of the Foreign Sovereign Immunities Act (FSIA). Electronic or hard-copy proposals must be received by NOON (EST) on April 3, 2017.
The hearing will examine the military technologies China is pursuing at the global technological frontier, its ability to develop innovative technologies going forward, and implications of these efforts for the United States.
High-speed rail is a symbol of China’s technological progress and a significant source of national pride. In under a decade, China built the world’s largest high-speed rail network and developed globally competitive rail companies. Now Beijing is pursuing contracts for high-speed rail projects abroad. This staff report examines China’s high-speed rail diplomacy and growing footprint in the U.S.…
China is an important market for U.S. firms, but policies outlined in the 13th Five-Year Plan seek to create new Chinese competitors that will be able to challenge U.S. companies abroad while slowly closing market opportunities in China for U.S. and other foreign firms in important high-tech sectors such as biopharmaceuticals, robotics, and aviation. This staff report analyzes the 13th Five-Year…
In December 2016, Sao Tome and Principe—a country consisting of a group of islands and islets off the western coast of central Africa—broke diplomatic relations with Taiwan, and re-established diplomatic relations with China. The issue brief describes what happened, what it means for Taiwan, and how it fits into a series of measures that Beijing has taken to pressure Taiwan since the election of…
Mass quantities of fentanyl, a low-cost and highly potent synthetic drug, are being produced in China and brought illegally to the United States, contributing to a growing U.S. opioid crisis. The rise of fentanyl in the United States can be traced back to China’s large chemical and pharmaceutical industries, which manufacture vast quantities of the drug and its analogues to export to the western…
This hearing will explore patterns of Chinese investment in the United States and implications for U.S. policymakers. Topics that will be examined include China’s increasing investments in strategic sectors, Chinese state-owned companies claiming sovereign immunity in U.S. courts, and duress acquisitions of U.S. entities by Chinese firms. The hearing will also cover the activities of Chinese…